van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manag. 2016;51:1070–90.

Article  Google Scholar 

Kwon JH. Overcoming barriers in cancer pain management. J Clin Oncol. 2014;32:1727–33.

PubMed  Article  Google Scholar 

Te Boveldt ND, Vernooij-Dassen MJ, Jansen A, Vissers KC, Engels Y. Pain is not systematically registered in Dutch medical oncology outpatients. Pain Pract. 2015;15:364–70.

Article  Google Scholar 

Breuer B, Fleishman SB, Cruciani RA, Portenoy RK. Medical oncologists’ attitudes and practice in cancer pain management: a national survey. J Clin Oncol. 2011;29:4769–75.

PubMed  Article  Google Scholar 

Oosterling A, te Boveldt N, Verhagen C, van der Graaf WT, Van Ham M, Van der Drift M, Vissers K, Engels Y. Neuropathic pain components in patients with cancer: prevalence, treatment, and interference with daily activities. Pain Pract. 2016;16:413–21.

PubMed  Article  Google Scholar 

Rayment C, Hjermstad MJ, Aass N, Kaasa S, Caraceni A, Strasser F, Heitzer E, Fainsinger R, Bennett MI. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study. Palliat Med. 2013;27:714–21.

PubMed  Article  Google Scholar 

Bouhassira D, Luporsi E, Krakowski I. Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer. Pain. 2017;158:1118–25.

PubMed  Article  Google Scholar 

WHO. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization; 2018.

Google Scholar 

Mercadante S. The use of opioids for treatment of cancer pain. Expert Opin Pharmacother. 2015;16:389–94.

CAS  PubMed  Article  Google Scholar 

Mercadante S. Cancer pain. Curr Opin Support Palliat Care. 2013;7:139–43.

PubMed  Article  Google Scholar 

Huang R, Jiang L, Liu H, et al. Comparative efficacy of therapeutics for chronic cancer pain: a Bayesian network analysis. J Clin Oncol. 2019;37:1742–52.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mercadante S. Reviewing without clinical background is detrimental for cancer pain management. Cancers (Basel). 2019;11:1005.

Article  Google Scholar 

Lemaire A, George B, Maindet C, Burnod A, Allano G, Minello C. Opening up disruptive ways of management in cancer pain: the concept of multimorphic pain. Support Care Cancer. 2019;27:3159–70.

PubMed  Article  Google Scholar 

Mercadante S. Opioid titration in cancer pain: a critical review. Eur J Pain. 2007;11:823–30.

CAS  PubMed  Article  Google Scholar 

Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. 480 Part 1: clinical considerations. J Pain Symptom Manag. 2001;21:144–50.

CAS  Article  Google Scholar 

Cherny N, Ripamonti C, Pereira J, et al. Expert working group of the European association of palliative care network strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19:2542–54.

CAS  PubMed  Article  Google Scholar 

Mystakidou K. Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II and III transfers. J Pain. 2004;5:119–32.

CAS  PubMed  Article  Google Scholar 

Mystakidou K, Befon S, Kouskouni E, et al. From codeine to transdermal for cancer pain control: a safety and efficacy clinical trial. Anticancer Res. 2001;21:2225–30.

CAS  PubMed  Google Scholar 

Mystakidou K, Befon S, Tsilika E, et al. Use of fentanyl TTS as a single opioid for cancer pain relief: a safety and efficacy trial in patients naive to mild of strong opioids. Oncology. 2002;62:9.

CAS  PubMed  Article  Google Scholar 

Mystakidou K, Tsilika E, Kouloulias V. Long-term cancer pain management in morphine pre-treated and opioid naive patients with transdermal fentanyl. Int J Cancer. 2003;107:486–92.

CAS  PubMed  Article  Google Scholar 

van Seventer R, Smit JM, Schipper RM, Wicks MA, Zuurmond WWA. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Curr Med Res Opin. 2003;19:457–69.

PubMed  Article  CAS  Google Scholar 

Vielvoye-Kerkmeer A, Mattern C, Uitendaal M. Transdermal fentanyl in opioid-naive cancer patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine. J Pain Symptom Manag. 2000;19:185–92.

CAS  Article  Google Scholar 

Maltoni M, Scarpi E, Modonesi C, Passardi A, Calpona S, Turriziani A, et al. A validation study of the WHO analgesic ladder: a twostep vs three-step strategy. Support Care Cancer. 2005;13:888–94.

PubMed  Article  Google Scholar 

Klepstad P, Kaasa S, Skauge M, Borchgrevink PC. Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation. Acta Anesthesiol Scand. 2000;44:656–64.

CAS  Article  Google Scholar 

Mercadante S, Porzio G, Ferrera P, et al. Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manag. 2006;31:242–7.

CAS  Article  Google Scholar 

Zheng RJ, Fu Y, Zhu J, et al. Long-term low-dose morphine for patients with moderate cancer pain is predominant factor effecting clinically meaningful pain reduction. Support Care Cancer. 2018;26:4115–20.

PubMed  Article  Google Scholar 

Bandieri E, Romero M, Ripamonti CI, et al. Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol. 2016;34:436–44.

CAS  PubMed  Article  Google Scholar 

Mercadante S, Porzio G, Ferrera P, et al. Low doses of transdermal fentanyl in opioid-naive patients with cancer pain. Curr Med Res Opin. 2010;26:2765–8.

CAS  PubMed  Article  Google Scholar 

Mercadante S, Porzio G, Ferrera P, et al. Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study. Clin Ther. 2009;31:2134–8.

CAS  PubMed  Article  Google Scholar 

Mercadante S, Adile C, Ferrera P, Pallotti MC, Ricci M, Bonanno G, Casuccio A. Methadone as first-line opioid for the management of cancer pain. Oncologist. 2022;27:323–7.

PubMed  PubMed Central  Article  Google Scholar 

Mercadante S, Villari P, Ferrera P, Casuccio A, Fulfaro F. Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer. 2002;95:203–8.

CAS  PubMed  Article  Google Scholar 

Mercadante S. Intravenous morphine for management of cancer pain. Lancet Oncol. 2010;11:484–9.

CAS  PubMed  Article  Google Scholar 

Koyyalagunta D, Bruera E, Solanki DR, Nouri KH, Burton AW, Toro MP, Bruel BM, Manchikanti L. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician. 2012;15(3 Suppl):ES39–58.

PubMed  Article  Google Scholar 

Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Opioids for cancer pain—an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7(7): CD012592.

PubMed  Google Scholar 

Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13:e58-68.

CAS  PubMed  Article  Google Scholar 

Portenoy RK, Foley KM. Inturrisi CE The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 1990;43:273–86.

PubMed  Article  Google Scholar 

Mercadante S, Arcuri E, Santoni A. Opioid-induced tolerance and hyperalgesia. CNS Drugs. 2019;33:943–95.

CAS  PubMed  Article  Google Scholar 

Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain. 2002;100:213–7.

CAS  PubMed  Article  Google Scholar 

Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manag. 2001;2001(21):338–54.

Article  Google Scholar 

Knudsen AK, Brunelli C, Kaasa S, Apolone G, Corli O, Montanari M, Fainsinger R, Aass N, Fayers P, Caraceni A, Klepstad P, European Palliative Care Research Collaborative; European Pharmacogenetic Study. Which variables are associated with pain intensity and treatment response in advanced cancer patients? Implications for a future classification system for cancer pain. Eur J Pain. 2011;15:320–7.

PubMed  Article  Google Scholar 

Mercadante S. Opioid metabolism and clinical aspects. Eur J Pharmacol. 2015;769:71–8.

CAS  PubMed  Article  Google Scholar 

Mercadante S, Bruera E. Opioid switching in cancer pain: from the beginning to nowadays. Crit Rev Oncol Hematol. 2016;99:241–8.

PubMed  Article  Google Scholar 

Mercadante S. Opioid rotation for cancer pain: rationale and clinicalaspects. Cancer. 1999;86:1856–66.